Valeant Pharmaceuticals hosts ribbon-cutting ceremony to celebrate renovation of U.S. headquarters in NJ

Expansion of its U.S. headquarters solidifies commitment to grow jobs and support the local economy

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today celebrated the completion of renovations to its U.S. headquarters in Bridgewater, New Jersey with a ribbon-cutting ceremony. The ceremony, which was attended by representatives from the New Jersey Economic Development Authority (EDA), New Jersey Chamber of Commerce, and local elected officials, marked a milestone in the company's history and signified Valeant's commitment to bring jobs to the State of New Jersey.

"We are delighted to be finished with the rebuilding project at our U.S. headquarters," said J. Michael Pearson, Chairman and CEO of Valeant Pharmaceuticals International, Inc. "New Jersey has been our U.S. home for over a decade now and we have found it to be an ideal business environment. There is a wealth of talented and experienced individuals here that have helped us grow over the years. We are committed to New Jersey and look forward to expanding our presence here."

Since joining New Jersey's robust life sciences sector in 2003, Valeant, formerly Biovail Corporation, has continued to grow and expand in the State. After receiving a Grow New Jersey Assistance grant as part of an Economic Development Authority program, the company began making significant investments in its facility to support the current and expected number of employees that it will house. In total, the company invested more $12 million in renovating the office building and utilized over 15 local contractors to complete the work. Valeant currently employs over 400 employees in New Jersey.

"Today's ceremony is further evidence that the State's work to attract and retain thriving businesses in the pharmaceutical industry, and the jobs they bring, is working," said Lt. Governor Guadagno. "After making a commitment in 2013 to grow its footprint and the number of quality, sustainable jobs here in New Jersey, Valeant kept its promises and also made significant investments in its U.S. headquarters that continue to benefit the local economy." 

 

Source:

Valeant Pharmaceuticals International, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.